NSECertificate under SEBI (Depositories and Participants) Regulations, 20182 Jul 2026 · 2 Jul 2026, 01:21 pm
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Jubilant Pharmova Limited · JUBLPHARMA
✦ AI SummaryRegulatory
Jubilant Pharmova Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018, received from M/s Alankit Assignments Limited, Registrar and Share Transfer Agent of the Company.
Analysis Scores
Earnings Impact1/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk1/10
Liquidity Impact1/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Jubilant Pharmova Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Attachments (1)
📄pdf
Download →
JUBLPHARMA_02072026132123_IntimationReg745signedQ1.pdf
View document text
July 02, 2026
BSE Limited National Stock Exchange of India Limited
Floor 25, P. J. Towers Exchange Plaza
Dalal Street, Fort Bandra Kurla Complex
Mumbai - 400 001 Bandra (E)
Mumbai - 400 051
Scrip Code: 530019 Symbol: JUBLPHARMA
Sub: Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations,
2018
Dear Sir/Madam,
In terms of Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, we are
enclosing a confirmation Certificate for the quarter ended on June 30, 2026 received from M/s Alankit
Assignments Limited, Registrar and Share Transfer Agent of the Company.
We request you to take the same on record.
Thanking you,
Yours faithfully,
For Jubilant Pharmova Limited
Naresh Kapoor
Company Secretary
Encl: as above
National Securities Depository Limited Trade Central Depository Services (India) Limited
World, A wing, 4th Floor, Kamala Mills Marathon Futurex, A-Wing, 25th Floor,
Compound, Lower Parel, NM Joshi Marg, Lower Parel,
Mumbai-400013 Mumbai-400013